Low Dose Naltrexone for Treatment of Pain in Patients With Fibromyalgia - Effect Via a Central Mechanism?
Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
This study evaluates the effect and mechanism of low dose naltrexone for treatment of pain in
patients with fibromyalgia. It s a randomised, double-blinded, placebo-controlled, cross-over
study.
It is a 2-center study that takes place at The Multidisciplinary Pain Center in Copenhagen
and at The Multidisciplinary Pain Center in Give.